Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Pramlintide on Top of Semaglutide in Obese People With Prediabetes

NCT06619015 is registered in ClinicalTrials.gov with Esbjerg Hospital - University Hospital of Southern Denmark as lead sponsor.

NCT NCT06619015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06619015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Pramlintide on Top of Semaglutide in Obese People With Prediabetes
Lead sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Phase
Phase 2/3
Overall status
Withdrawn
Start date
April 1, 2025
Completion date
April 1, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appetite regulation, obesity, prediabetes